Skip to content

UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers

Umbilical Cord Mesenchymal Stem Cells Between Gel Treatment Difficult Skin Ulcer Healing Efficacy and Safety of Random, Open, Before-and-after Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02685722
Acronym
UC-MSCs
Enrollment
20
Registered
2016-02-19
Start date
2012-01-31
Completion date
2015-12-31
Last updated
2016-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult to Healing of Skin Ulcers

Brief summary

This study for a six-month trials, Randomized, open, and parallel comparison before and after its own, Stage test includes screening stage, treatment period and follow-up period. In accordance with chronic wound criteria for the patient, By producing the principle of random number, Were randomly divided into UC-MSCs Gel group or Gel group, The researchers according to the situation of wound healing time and decided to use the secondary treatment, To observe the clinical efficacy and safety.

Interventions

BIOLOGICALUC-MSCs Gel group

This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.By generating a random number of principle,Observation of UC-MSCs Gel group patients efficacy, safety and tolerability of selective parameter.

This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.By generating a random number of principle,observed and compared Gel group patients may be no efficacy.

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
17 Years to 78 Years
Healthy volunteers
Yes

Inclusion criteria

* Older than 17 year old male or female (pregnancy); * Has the ability to care for, has the ability to self signed informed consent, 7 to 17 years of age must be signed by the guardian informed consent; * The process of psychological stability, can finish the tes

Exclusion criteria

* Allergic constitution, or known allergic to pork or beef source products, gao min physique person; * The wound is more than 10 cm by 10 cm; * People with mental illness, drug abusers and or other items; * 1 month used or are using the sugar metabolism of drugs, such as corticosteroids, thiazide diuretics, tricyclic antidepressants, etc; * 3 month participated in other similar test; * Serious infectious disease not controller; * With surgery, such as severe trauma stress situation; * Always had a history of tumor; * Clinical researchers or for other reasons can't cooperate with the doctors, and other information is not suitable for clinical study of patients.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of Adverse Events6 monthsFrequency and severity of Adverse Events

Secondary

MeasureTime frame
Relative Wound Area Regression of 40% or More at 6 Week6 week

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026